Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Cipher Pharmaceuticals Inc banner

Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 14.86 CAD 2.41% Market Closed
Market Cap: CA$377.6m
Write Note Create Alert Ask AI

Wall St Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 19.89 CAD with a low forecast of 4.04 CAD and a high forecast of 22.37 CAD.

CPH Lowest Forecast
Wall Street Target
CA$4.04
-73% Downside
CPH Average Forecast
Wall Street Target
CA$19.89
34% Upside
CPH Highest Forecast
Wall Street Target
CA$22.37
51% Upside
Lowest Forecast
Price Target
4.04 CAD
73% Downside
Average Forecast
Price Target
19.89 CAD
34% Upside
Highest Forecast
Price Target
22.37 CAD
51% Upside
Cipher Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Gross Profit over the next 3 years is 20%.

What are analyst estimates?

Operating Income
Forecast

16% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
16% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is 31%.

What are analyst estimates?

Pre-Tax Income
Forecast

16% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
16% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 31%.

What are analyst estimates?

Net Income
Forecast

20% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat
20% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Continue CPH Research

Summary
CPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
CPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CPH stock valuation using valuation multiples.
Wall St Estimates
CPH price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Cipher Pharmaceuticals Inc listings:
OTC • USD
CPHRF
 F • EUR
PHE
 SWB • EUR
PHE
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CPH's stock price target?
Price Target
19.89 CAD

According to Wall Street analysts, the average 1-year price target for CPH is 19.89 CAD with a low forecast of 4.04 CAD and a high forecast of 22.37 CAD.

What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
20%

The compound annual growth rate for Gross Profit over the next 3 years is 20%.

What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is 31%.

What is the Pre-Tax Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 31%.

What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 9%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.